Artificial Intelligence: Novartis And Microsoft Team Up to Transform Global Medicine

A collaboration between multinational pharmaceutical company Novartis and technological giant Microsoft aims to bring AI to the desk of every Novartis employee.

Novartis announced its plan for founding the Novartis AI innovation lab in collaboration with Microsoft as the AI and data-science partner. The Novartis-Microsoft alliance will “reimagine medicine” and boost Novartis’ AI capabilities. The new lab will discover and develop transformative medicine for patients globally.

Novartis-Microsoft alliance in multi-year R&D effort

The new lab will be the centerpiece of the collaboration and focus on a two-pronged objective.

‘AI Empowerment’ will make Novartis datasets and Microsoft’s AI solutions accessible to every Novartis associate.

‘AI Exploration’ will harness AI to tackle the most difficult computational challenges faced by the life sciences industry.

Further, the Novartis-Microsoft alliance will develop AI applications for future lab programs.

Microsoft AI

Microsoft AI helps transform business by driving innovation. It is already in use at The Hershey Company, NHS Glasgow and Clyde, BP, and Schneider Electric.

For example, Schneider developed a predictive analytics solution based on machine learning and IoT. Energy producers use it to monitor remote equipment — saving maintenance costs, optimizing production, and increasing safety for workers and the environment.

Also, Microsoft focused on transforming healthcare through AI and the cloud. Furthermore, the company announced the availability of the Microsoft Genomics service on Azure last year.

Meanwhile, Azure provides researchers, data scientists, and clinicians cloud-powered genomic processing services to handle huge data workloads.

Microsoft also launched last year the Azure Security and Compliance Blueprint: HIPAA/HITRUST – Health Data & AI provides a secure and automated environment to build applications that manage sensitive and regulated data.

Novartis-Microsoft alliance to reimagine medicine

Finally, the deal will likely bolster the development of new medicines.

“Pairing our deep knowledge of human biology and medicine with Microsoft’s leading expertise in AI could transform the way we discover and develop medicines for the world,” said Vas Narasimhan, CEO of Novartis.


Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
Artificial Intelligence: AMD Takes On Rivals In The AI Chip Sweepstakes
December 7, 2023     Artificial Intelligence, News

Chipmaker AMD (NASDAQ: AMD) has unveiled a range of innovative AI solutions spanning from data centers to personal computers. The AMD Instinct MI300 Series features data center AI accelerators, while…
Digital Assets: Robinhood Debuts Crypto Trading On Its App In The EU
December 7, 2023     Digital Assets, FinTech, News

Robinhood (NASDAQ: HOOD) has launched its Crypto app in the European Union (EU), allowing eligible customers to engage in crypto trading with the added incentive of earning Bitcoin rewards. Customers…
FinTech: Samsung Electronics Ties With Mastercard’s Wallet Express
December 7, 2023     FinTech, News

Samsung Electronics (KRX: 005930) and Mastercard (NYSE: MA) have partnered to launch the Wallet Express program, offering banks and card issuers a cost-effective way to expand digital wallet offerings. Through…
Venture Capital: Revaia, Europe’s Biggest Female-Led VC Firm, Racks Up $160M For Second Fund
December 7, 2023     ESG and Sustainability, News, Venture Capital

Revaia, Europe’s largest female-founded venture capital firm, has successfully raised €150 million ($160 million) for its second fund, Revaia Growth II. The funding was secured from sovereign wealth funds, family…